InStride Raises $30M to Scale Pediatric Mental Health Support
InStride’s Series C round includes support from new investors Echo Health Ventures and FMZ Ventures,…
InStride Raises $30M to Scale Pediatric Mental Health Support
InStride’s Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. The post InStride Raises $30M to Scale Pediatric Mental Health Support appeared first on MedCity News.
New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug
MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News.
What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak
Verily is testing wastewater across World Cup host cities for pathogens like RSV, measles and norovirus, aiming to spot outbreaks five to seven days before they show up in clinics. The post What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak appeared first on MedCity News.
Out-of-Pocket Costs for Long-Acting Reversible Contraception Among Individuals Enrolled in Employer Sponsored Insurance Plans
In this analysis, published in the journal Contraception, KFF’s Linda Li, Brittni Frederiksen, and Alina Salganicoff look at intrauterine device (IUD) and contraceptive implant insertion-related costs among privately insured individuals to better understand why patients are experiencing unexpected expenses for what should be fully covered contraceptive services under the ACA.
State Choices, Unequal Access: Policies Shaping Reproductive Health Care Across the United States
Authored by KFF’s Alina Salganicoff, Ivette Gomez, and Usha Ranji, this article for The Milbank Quarterly examines how state policies create varying levels of access to reproductive healthcare services.
Recent State Actions Related to Immigrants’ Access to Services and Immigration Enforcement
This brief summarizes recent and proposed actions by states related to access to state-funded health coverage and other services for immigrants and immigration enforcement activity during the 2025 and 2026 state legislative sessions.
The Missing Vital Sign: Why Modern Medicine Still Won’t Measure Sleep
By COLIN LAWLOR A patient comes in for an ordinary primary care appointment. The nurse runs through the usual checklist: temperature, blood pressure, pulse, weight, sometimes pulse oximetry. Sleep probably won’t come up. If it does, it will be a side note, and if the patient says, “not great,” what often follows is a brief…
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial designs and the complexities of diseases such as certain cancers and rare disorders, which may lead to more efficient trials, lower development costs, and faster innovation. The post The FDA’s Bayesian Guidance Could Quietly Reshape Clinical…
Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation
Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other component of care delivery. That requires these three things. The post Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation appeared first on MedCity News.
Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare
The autonomous healthcare system is about to take shape, and health systems must prepare to evolve alongside it. The post Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare appeared first on MedCity News.
